Business Development

HNSP is expandingits business to serve the international market for chemically synthesized peptide drugs and APIs. Current international expansion opportunities include: 
• Active pharmaceutical ingredient (API) and finished product export 
• Merger with / acquisition of pharmaceutical companies outside China
• Providing contract manufacturing services to international pharmaceutical firms
• Collaborating with a variety of foreign pharmaceutical partners and selling their products in China  
• Cooperating with foreign pharmaceutical formulation companies with HNSP-developed active pharmaceutical ingredients (APIs) 
• Introducing novel technologies, including sustained release formulations
• Partnering with pharmaceutical companies outside China to manufacture, market and sell HNSP-developed active pharmaceutical ingredients (APIs) in their countries